Axa
FPRX

Axa’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Axa’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-146,371
Closed -$672K – 1284
2019
Q4 		$672K Sell
146,371
-171,905
-54% -$681K ﹤0.01% 948
2019
Q3 		$1.23M Sell
318,276
-242,845
-43% -$1.33M ﹤0.01% 954
2019
Q2 		$3.38M Sell
561,121
-13,799
-2% -$132K 0.01% 753
2019
Q1 		$7.7M Buy
574,920
+208,543
+57% +$2.38M 0.03% 527
2018
Q4 		$3.41M Buy
+366,377
New +$4.36M 0.01% 699
2018
Q2 		– Sell
-220,413
Closed -$3.79M – 1435
2018
Q1 		$3.79M Buy
220,413
+87,548
+66% +$1.71M 0.02% 724
2017
Q4 		$2.91M Sell
132,865
-138
-0.1% -$4.44K 0.01% 781
2017
Q3 		$5.44M Buy
+133,003
New +$4.18M 0.02% 606
2017
Q2 		– Sell
-15,400
Closed -$557K – 1324
2017
Q1 		$557K Buy
15,400
+6,700
+77% +$295K ﹤0.01% 1055
2016
Q4 		$436K Sell
8,700
-39,900
-82% -$2.1M ﹤0.01% 1080
2016
Q3 		$2.55M Sell
48,600
-6,200
-11% -$296K 0.01% 701
2016
Q2 		$2.27M Buy
+54,800
New +$2.38M 0.01% 720

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Axa's FPRX Position: Q1 2020 in Review

Axa sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2020, closing a stake of 146,371 shares — an estimated $672K sold.

Axa first reported a position in FPRX in Q2 2016 and held it in 12 quarters. The position peaked at $7.7M in Q1 2019. 87 funds tracked by Wall St. Rank hold FPRX as of Q1 2020.

  • Axa reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
  • Axa sold 146,371 Five Prime Therapeutics, Inc. shares in Q1 2020, an estimated $672K.
  • Axa first reported a position in Five Prime Therapeutics, Inc. in Q2 2016 and held it in 12 quarters.
  • Axa's Five Prime Therapeutics, Inc. position peaked at $7.7M in Q1 2019.
  • 87 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2020.

Based on Axa's 13F filing for Q1 2020, filed 15 May 2020.